Log In
BCIQ
Print this Print this
 

18F-DCFPyL, PyL

  Manage Alerts
Collapse Summary General Information
Company Progenics Pharmaceuticals Inc.
DescriptionFluorinated PSMA-targeted PET imaging agent
Molecular Target Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
Mechanism of ActionImaging agent
Therapeutic ModalityDiagnostics: Radiologic imaging
Latest Stage of DevelopmentPhase II/III
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose prostate cancer; PET imaging agent for prostate cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today